Pelthos Therapeutics Inc. Basic Shares Outstanding (Weighted Average)
Pelthos Therapeutics Inc. (PTHS) reported Basic Shares Outstanding (Weighted Average) of 3.54 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 3.54M shares, a 442.93% increase year-over-year.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 3.31M shares, a 440.35% increase year-over-year.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 3.18M shares, a 426.70% increase year-over-year.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.06M shares, a 428.55% increase year-over-year.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.88M shares, a 237.34% increase from fiscal 2024.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 557.45K shares, a 56.33% decline from fiscal 2023.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.28M shares, a 193.25% increase from fiscal 2022.
- Pelthos Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 435.31K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.54M shares 10-Q · filed 2026-08-13 | 3.43M shares 10-Q · filed 2026-08-13 | 3.34M shares derived: average of 3 quarters · filed 2026-08-13 | 3.27M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 3.31M shares 10-Q/A · filed 2026-08-13 | 3.25M shares derived: average of 2 quarters · filed 2026-08-13 | 3.18M shares derived: average of 3 quarters · filed 2026-08-13 | 2.55M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 3.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 3.12M shares derived: average of 2 quarters · filed 2026-03-19 | 2.30M shares derived: average of 3 quarters · filed 2026-08-13 | 1.88M shares 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | 3.06M shares 10-Q · filed 2025-11-13 | 1.86M shares derived: average of 2 quarters · filed 2026-08-13 | 1.45M shares 10-Q · filed 2025-11-13 | 1.23M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 651.92K shares 10-Q · filed 2026-08-13 | 640.52K shares 10-Q · filed 2025-08-13 | 632.51K shares 10-Q · filed 2026-08-13 | 626.74K shares 10-Q · filed 2025-08-13 | 622.83K shares derived: average of 3 quarters · filed 2026-08-13 | 611.93K shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 612.89K shares 10-Q/A · filed 2026-08-13 | 6.13M shares 10-Q · filed 2025-05-13 | 608.28K shares derived: average of 2 quarters · filed 2026-08-13 | 598.60K shares derived: average of 3 quarters · filed 2026-08-13 | 593.29K shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2024-12-31 | 603.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 591.45K shares derived: average of 2 quarters · filed 2026-03-19 | 586.76K shares derived: average of 3 quarters · filed 2026-03-19 | 557.45K shares 10-K · filed 2026-03-19 | 5.57M shares 10-K · filed 2025-03-27 | |||
| 2024-09-30 | 579.23K shares 10-Q · filed 2025-11-13 | 5.79M shares 10-Q · filed 2024-11-13 | 578.30K shares derived: average of 2 quarters · filed 2025-11-13 | 542.04K shares 10-Q · filed 2025-11-13 | 5.42M shares 10-Q · filed 2024-11-13 | 1.96M shares derived: average of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 577.37K shares 10-Q · filed 2025-08-13 | 5.77M shares 10-Q · filed 2024-08-13 | 523.24K shares 10-Q · filed 2025-08-13 | 5.23M shares 10-Q · filed 2024-08-13 | 2.43M shares derived: average of 3 quarters · filed 2025-08-13 | 2.07M shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 4.69M shares 10-Q · filed 2025-05-13 | 3.35M shares derived: average of 2 quarters · filed 2025-05-13 | 2.56M shares derived: average of 3 quarters · filed 2025-05-13 | 2.17M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 2.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 1.50M shares derived: average of 2 quarters · filed 2025-03-27 | 1.33M shares derived: average of 3 quarters · filed 2025-03-27 | 1.28M shares 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | 984.52K shares 10-Q · filed 2024-11-13 | 993.65K shares derived: average of 2 quarters · filed 2024-11-13 | 1.03M shares 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | 1.00M shares 10-Q · filed 2024-08-13 | 1.06M shares 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | 1.11M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 435.31K shares 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |